1. Home
  2. HYFT vs PFX Comparison

HYFT vs PFX Comparison

Compare HYFT & PFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HYFT
  • PFX
  • Stock Information
  • Founded
  • HYFT 1983
  • PFX 2010
  • Country
  • HYFT United States
  • PFX United States
  • Employees
  • HYFT N/A
  • PFX N/A
  • Industry
  • HYFT Biotechnology: Pharmaceutical Preparations
  • PFX Finance: Consumer Services
  • Sector
  • HYFT Health Care
  • PFX Finance
  • Exchange
  • HYFT Nasdaq
  • PFX Nasdaq
  • Market Cap
  • HYFT 80.8M
  • PFX 96.4M
  • IPO Year
  • HYFT 2017
  • PFX N/A
  • Fundamental
  • Price
  • HYFT $1.68
  • PFX $42.39
  • Analyst Decision
  • HYFT
  • PFX
  • Analyst Count
  • HYFT 0
  • PFX 0
  • Target Price
  • HYFT N/A
  • PFX N/A
  • AVG Volume (30 Days)
  • HYFT 385.5K
  • PFX 1.6K
  • Earning Date
  • HYFT 12-09-2025
  • PFX 12-16-2025
  • Dividend Yield
  • HYFT N/A
  • PFX 3.37%
  • EPS Growth
  • HYFT N/A
  • PFX N/A
  • EPS
  • HYFT N/A
  • PFX 3.06
  • Revenue
  • HYFT $18,214,531.00
  • PFX $23,958,590.00
  • Revenue This Year
  • HYFT N/A
  • PFX $10.24
  • Revenue Next Year
  • HYFT $71.78
  • PFX N/A
  • P/E Ratio
  • HYFT N/A
  • PFX $13.86
  • Revenue Growth
  • HYFT 18.33
  • PFX 7.47
  • 52 Week Low
  • HYFT $0.27
  • PFX $41.80
  • 52 Week High
  • HYFT $3.25
  • PFX $57.40
  • Technical
  • Relative Strength Index (RSI)
  • HYFT N/A
  • PFX 36.02
  • Support Level
  • HYFT N/A
  • PFX $42.12
  • Resistance Level
  • HYFT N/A
  • PFX $43.50
  • Average True Range (ATR)
  • HYFT 0.00
  • PFX 0.69
  • MACD
  • HYFT 0.00
  • PFX -0.03
  • Stochastic Oscillator
  • HYFT 0.00
  • PFX 5.64

About HYFT MindWalk Holdings Corp. Common Stock

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

Share on Social Networks: